Concepedia

Jiabu Ye

JY

9

Publications

397

Citations

9

H-Index

2019

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (United States)

AstraZeneca (Japan)

Columbia University Irving Medical Center

UPMC Hillman Cancer Center

Jiabu Ye is an author at AstraZeneca (United Kingdom) specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2019–2023

9

Publications

9

A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study

Han Si, Michael Kuziora, Katie Quinn et al. · Clinical Cancer Research · 2020 · 109 citations · Full text

Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients

Sriram Sridhar, Luis Paz‐Ares, Hao Liu et al. · Clinical Lung Cancer · 2019 · 58 citations · Full text

OA04.07 Mutations Associated with Sensitivity or Resistance to Immunotherapy in mNSCLC: Analysis from the MYSTIC Trial

Naiyer A. Rizvi, Byoung Chul Cho, Niels Reinmuth et al. · Journal of Thoracic Oncology · 2019 · 56 citations · Full text

, , +11

Robust Design and Analysis of Clinical Trials With Nonproportional Hazards: A Straw Man Guidance From a Cross-Pharma Working Group

Satrajit Roychoudhury, Keaven M. Anderson, Jiabu Ye et al. · Statistics in Biopharmaceutical Research · 2021 · 51 citations · Full text

, , +19

Correlation Between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-Analysis

Khader Shameer, Youyi Zhang, Dan Jackson et al. · Frontiers in Oncology · 2021 · 34 citations · Full text

Rows per page

1–5 of 9